Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Chemoprevention of Anal Neoplasia Arising Secondary to Anogenital Human Papillomavirus Infection in Persons With HIV Infection.
This study has been completed.
Study NCT00000764 Information provided by National Institute of Allergy and Infectious Diseases (NIAID)
First Received: November 2, 1999 Last Updated: August 1, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
HIV Infections
Anus Neoplasms
Additional conditions recognized in this trial
Acquired Immunodeficiency Syndrome
Communicable Diseases
Infection
Neoplasms
Papillomavirus Infections
Warts
More general conditions related to this trial
Anus Diseases
Colorectal Neoplasms
Digestive System Diseases
Digestive System Neoplasms
DNA Virus Infections
Gastrointestinal Diseases
Gastrointestinal Neoplasms
Immune System Diseases
Immunologic Deficiency Syndromes
Intestinal Diseases
Intestinal Neoplasms
Lentivirus Infections
Neoplasms by Site
Rectal Diseases
Rectal Neoplasms
Retroviridae Infections
RNA Virus Infections
Sexually Transmitted Diseases
Sexually Transmitted Diseases, Viral
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Viral
Slow Virus Diseases
Tumor Virus Infections
Virus Diseases
Interventions listed in this trial
Isotretinoin
Interferon alfa-2a
Additional drug interventions recognized in this trial
Interferon-alpha
Interferons
More general drug interventions related to this trial
Angiogenesis Inhibitors
Angiogenesis Modulating Agents
Anti-Infective Agents
Antineoplastic Agents
Antiviral Agents
Dermatologic Agents
Growth Inhibitors
Growth Substances
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute of Allergy and Infectious Diseases (NIAID)
Hoffmann-La Roche
Back to top of Main Content
